CHINOOK THERAPEUTICS INC (KDNY) Stock Balance Sheet
NASDAQ:KDNY - Nasdaq - US16961L1061 - Common Stock - Currency: USD
| MRQ (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 127.15M | 115.44M | 181.72M | 187.80M | 59.60M | |||
| Marketable Securities | 170.02M | 262.89M | 105.11M | 59.60M | 154.00M | |||
| Receivables | 3.10M | 1.09M | 10.06M | 300.00K | 300.00K | |||
| Other Current Assets | 5.15M | 6.18M | 3.74M | 6.40M | 4.00M | |||
| Total Current Assets | 305.42M | 385.59M | 300.64M | 254.10M | 217.90M | |||
| Non-Current Assets | ||||||||
| PPE Net | 59.11M | 65.88M | 74.32M | 76.30M | 45.80M | |||
| Investments And Advances | 47.96M | 52.26M | 117.62M | 3.00M | 0.00 | |||
| Goodwill | 117.00K | 117.00K | 117.00K | 22.40M | 8.20M | |||
| Intangibles | 59.97M | 60.84M | 62.56M | 67.00M | 19.00M | |||
| Other Non-Current Assets | 16.24M | 9.40M | 8.55M | 6.20M | 500.00K | |||
| Total Non-Current Assets | 183.39M | 188.49M | 263.16M | 174.90M | 73.40M | |||
| TOTAL ASSETS | 488.81M | 574.08M | 563.80M | 429.00M | 291.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 0.00 | N/A | |||
| Accrued Expenses | 33.61M | 38.58M | 21.50M | 17.80M | 14.20M | |||
| Accounts Payable | 16.36M | 9.75M | 8.58M | 4.00M | 400.00K | |||
| Other Current Liabilities | 2.50M | 2.50M | 10.00M | 1.00M | 7.00M | |||
| Total Current Liabilities | 52.47M | 50.84M | 40.09M | 22.80M | 21.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | 5.08M | 5.08M | 735.00K | 16.40M | 3.50M | |||
| Other Non-Current Liabilities | 74.22M | 76.23M | 69.34M | 55.20M | 200.60M | |||
| Total Non-Current Liabilities | 79.30M | 81.31M | 70.08M | 71.60M | 204.10M | |||
| TOTAL LIABILITIES | 131.77M | 132.14M | 110.16M | 94.40M | 225.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -546.75M | -419.63M | -231.77M | -128.80M | -486.90M | |||
| Additional Paid In Capital | 905.11M | 864.73M | 685.46M | 463.40M | 552.10M | |||
| Common Shares | 7.00K | 7.00K | 5.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -1.32M | -3.16M | -55.00K | 0.00 | 400.00K | |||
| Shares Outstanding | 67.08M | 65.47M | 54.76M | 42.30M | 16.10M | |||
| Tangible Book Value per Share | 4.43 | 5.82 | 7.14 | 5.80 | 2.39 | |||
| Total Shareholders' Equity | 357.04M | 441.94M | 453.64M | 334.60M | 65.60M | |||
| TOTAL LIABILITIES AND EQUITY | 488.81M | 574.08M | 563.80M | 429.00M | 291.30M | |||
| Statistics | ||||||||
| Current Ratio | 5.82 | 7.59 | 7.50 | 11.14 | 10.09 | |||
| Return On Assets (ROA) | -50.26% | -32.72% | -18.26% | -19.03% | -28.28% | |||
| Return On Equity (ROE) | -68.80% | -42.51% | -22.69% | -24.39% | -125.56% | |||
All data in USD , ROIC based on taxRate of 0.21